IS CAPECITABINE EFFICACIOUS IN TRIPLE NEGATIVE METASTATIC BREAST CANCER?

被引：0
|
作者：
Kotsori, A. [1 ]
Dolly, S.
Sheri, A.
Ashley, S. [1 ]
Walsh, G. [1 ]
Shaunak, N. [1 ]
Johnston, S. R. D. [2 ,3 ]
Smith, I. [4 ]
机构：
[1] Royal Marsden Hosp, Breast Unit Med Oncol, London SW3 6JJ, England
[2] Royal Marsden NHS Fdn Trust, Breast Unit, London, England
[3] Inst Canc Res, London SW3 6JB, England
[4] Royal Marsden Hosp, Dept Med, London SW3 6JJ, England
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [21] Iniparib in Metastatic Triple-Negative Breast Cancer
    Domagala, Pawel
    Lubinski, Jan
    Domagala, Wenancjusz
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18): : 1780 - 1780
  • [22] The evolving management of metastatic triple negative breast cancer
    Malhotra, Monica K.
    Emens, Leisha A.
    SEMINARS IN ONCOLOGY, 2020, 47 (04) : 229 - 237
  • [23] EGFR INHIBITOR IN METASTATIC TRIPLE NEGATIVE BREAST CANCER
    Payandeh, M.
    Aeinfar, M.
    Zare, M. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 44 - 44
  • [24] RIBBON-1: efficacy of capecitabine-bevacizumab in patients with triple-negative metastatic breast cancer (MBC)
    Lindman, H.
    Lipatov, O.
    Bondarenko, I.
    Panasci, L.
    Coleman, R.
    EJC SUPPLEMENTS, 2010, 8 (03): : 204 - 204
  • [25] Primary systemic therapy with metronomic doxorubicin, cyclophosphamide, and capecitabine in locally advanced and metastatic triple-negative breast cancer
    Skrypnikova, M.
    Frolova, M.
    Ignatova, E.
    Pokataev, I.
    Stenina, M.
    Tjulandin, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Pembrolizumab (pembro) with paclitaxel (taxol) or capecitabine (cape) as early treatment of metastatic triple-negative breast cancer (mTNBC).
    Page, David B.
    Chun, Brie
    Pucilowska, Joanna
    Kim, Isaac
    Sanchez, Katherine
    Redmond, William L.
    Sun, Zhaoyu
    Wu, Yaping
    Feryn, Alicia
    Martel, Maritza
    Abaya, Christina DiLauro
    Wadell, Dottie
    Mellinger, Staci L.
    Moxon, Nicole
    Urba, Walter John
    McAndrew, Philomena
    El-Masry, Maryliza
    Basho, Reva K.
    Conlin, Alison Katherine
    McArthur, Heather L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer
    Laird, James
    Leventhal, Jonathan
    Kanowitz, Jane
    Damast, Shari
    PRACTICAL RADIATION ONCOLOGY, 2021, 11 (06) : 448 - 452
  • [28] Therapeutic effects of epirubicin combined with capecitabine for patients with triple negative breast cancer
    Zhang, Yan
    Ye, Zhen
    Chen, Zhongnan
    Yang, Meng
    Yu, Dapeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (10): : 12400 - 12409
  • [29] Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer
    Lin, Kun
    Michaels, Elena
    Polley, Eric
    O'Donnell, Peter H.
    Howard, Frederick M.
    Hahn, Olwen
    Fleming, Gini F.
    Nanda, Rita
    Chen, Nan
    Yang, Heng
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [30] Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer
    Lin, Kun
    Michaels, Elena
    Polley, Eric
    O'Donnell, Peter H.
    Howard, Frederick Matthew
    Conzen, Suzanne D.
    Hahn, Olwen Mary
    Fleming, Gini F.
    Nanda, Rita
    Chen, Nan
    Yang, Heng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345